
‘A Giant Ship With a Rusty Rudder’: What Six Weeks of Cannabis Rescheduling Has and Hasn’t Changed
On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA

On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA

Trulieve’s uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every

Cannabis stocks have, for the last five years or so, represented one of, if not the worst-performing, niche categories on

Having spent over 30 years in advisory roles in financial markets prior to entering the cannabinoid industry, I lived through

After years of false starts, political delays and administrative paralysis, the United States federal government has taken its first concrete

The Trump administration’s continued inaction on its promise to push ahead with the highly anticipated cannabis rescheduling project is now

Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through

US cannabis companies have endured a significant selloff in the days following the results of the election, seeing $2.6bn wiped off their collective market capitalization.

Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped

Florida based cannabis giant Trulieve has agreed to pay a settlement fine of $350,000 following the death of one of

This week, a swathe of North America’s largest cannabis companies reported thier most recent financial results, revealing slimming but continued

The US Drug Enforcement Administration (DEA) has confirmed that it is conducting a review into the reclassification of cannabis, but

A Florida State Senator has filed a proposal which would relieve the 280E tax burden on medical cannabis businesses. The

The Alabama Medical Cannabis Commission (AMCC) have succeeded in awarding licences to five vertically integrated medical cannabis facilities after a long and complex legal battle.

US cannabis MSO Trulieve published its third quarter results this morning, revealing that the company has been able to reduce

This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A

At a recent meeting of the Georgia Access to Medical Cannabis Commission, the board voted to approve three new cannabis

US cannabis giant Trulieve has filed a civil lawsuit against its former business partners in a bid to recover unpaid